Mun Mingyon, Kohno Tadasu
Department of Thoracic Surgery, Toranomon Hospital, Tokyo, Japan.
Ann Thorac Surg. 2007 Mar;83(3):1146-51. doi: 10.1016/j.athoracsur.2006.10.037.
The rate of detection of synchronous bilateral multiple lung cancers (SBMLC) has increased. We evaluated applicability and efficacy of single-stage surgical treatment of SBMLC patients encountered in our department.
In a retrospective examination of 674 patients who underwent surgical treatment of primary lung cancers at our department between 1999 and 2004, single-stage surgical treatment was used in 19 patients. Clinical and histologic features, approaches, and outcomes of surgical treatments were studied retrospectively.
The 19 patients (6 men, 13 women) were a median age of 65.8 years (range, 52 to 80 years). At operation, all 11 patients (58%) were women with no history of smoking. Lobectomy and wedge resection on the opposite side were performed in 13 patients, segmentectomy and wedge resection were performed in 1, and bilateral wedge resection was done in 5. Postoperative histopathologic examination revealed that 84 lesions were adenocarcinomas and three were squamous cell carcinomas. All pure ground glass opacities (GGOs) measuring less than 10 mm in diameter on high-resolution computed tomography imaging were diagnosed as bronchioloalveolar carcinoma (BAC) type A or B. No patients died perioperatively. The median postoperative observation period was 44 months. Overall survival rates were 94.7% at 3 years and 75.8% at 5 years. In cases of multifocal BAC after resection, development of new lesions was observed in 4 patients.
Single-stage bilateral surgical treatment of SBMLC yielded satisfactory results in our selected patients; however, appearance of new lesions remains a problem.
同期双侧多发性肺癌(SBMLC)的检出率有所上升。我们评估了在本部门遇到的SBMLC患者进行一期手术治疗的适用性和疗效。
回顾性分析1999年至2004年间在本部门接受原发性肺癌手术治疗的674例患者,其中19例采用一期手术治疗。对手术治疗的临床和组织学特征、手术方式及结果进行回顾性研究。
19例患者(6例男性,13例女性),中位年龄65.8岁(范围52至80岁)。手术时,11例患者(58%)为无吸烟史女性。13例行肺叶切除术及对侧楔形切除术,1例行肺段切除术及楔形切除术,5例行双侧楔形切除术。术后组织病理学检查显示84个病灶为腺癌,3个为鳞状细胞癌。高分辨率计算机断层扫描成像上所有直径小于10 mm的纯磨玻璃影(GGO)均诊断为A或B型细支气管肺泡癌(BAC)。无患者围手术期死亡。术后中位观察期为44个月。3年总生存率为94.7%,5年为75.8%。切除术后多灶性BAC患者中,4例观察到新病灶出现。
在我们选择的患者中,SBMLC的一期双侧手术治疗取得了满意的结果;然而,新病灶的出现仍然是一个问题